Koninklijke Philips (NYSE:PHG – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Monday, July 24th. Analysts expect Koninklijke Philips to post earnings of $0.23 per share for the quarter.
Koninklijke Philips (NYSE:PHG – Get Free Report) last posted its quarterly earnings results on Monday, April 24th. The technology company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.05. Koninklijke Philips had a positive return on equity of 6.29% and a negative net margin of 11.63%. The business had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $3.99 billion. During the same quarter in the previous year, the business earned $0.32 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, analysts expect Koninklijke Philips to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Koninklijke Philips Stock Performance
PHG opened at $22.73 on Monday. The company has a current ratio of 1.29, a quick ratio of 0.78 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $21.11 billion, a PE ratio of -9.28 and a beta of 0.94. The firm has a 50 day moving average of $20.49 and a two-hundred day moving average of $18.54. Koninklijke Philips has a 12-month low of $11.75 and a 12-month high of $22.98.
Koninklijke Philips Cuts Dividend
Wall Street Analyst Weigh In
Several brokerages have issued reports on PHG. Citigroup lifted their target price on shares of Koninklijke Philips to €19.00 ($20.88) in a research note on Friday, July 7th. The Goldman Sachs Group initiated coverage on shares of Koninklijke Philips in a research note on Wednesday, July 12th. They set a “buy” rating on the stock. Societe Generale upgraded shares of Koninklijke Philips from a “sell” rating to a “hold” rating in a research note on Tuesday, April 25th. Finally, StockNews.com started coverage on Koninklijke Philips in a report on Thursday, May 18th. They issued a “hold” rating for the company. Four equities research analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $17.06.
Institutional Investors Weigh In On Koninklijke Philips
A number of large investors have recently added to or reduced their stakes in the stock. Wellington Management Group LLP grew its holdings in Koninklijke Philips by 16.7% during the 1st quarter. Wellington Management Group LLP now owns 8,245,236 shares of the technology company’s stock worth $251,727,000 after acquiring an additional 1,178,744 shares during the period. BlackRock Inc. raised its stake in shares of Koninklijke Philips by 29.0% during the first quarter. BlackRock Inc. now owns 6,633,477 shares of the technology company’s stock valued at $121,724,000 after acquiring an additional 1,492,764 shares during the last quarter. Morgan Stanley grew its holdings in Koninklijke Philips by 9.9% in the fourth quarter. Morgan Stanley now owns 3,351,702 shares of the technology company’s stock worth $50,242,000 after purchasing an additional 302,633 shares during the period. Bank of America Corp DE lifted its position in Koninklijke Philips by 14.8% during the first quarter. Bank of America Corp DE now owns 2,476,359 shares of the technology company’s stock valued at $45,441,000 after purchasing an additional 319,451 shares during the period. Finally, Thompson Siegel & Walmsley LLC raised its position in shares of Koninklijke Philips by 1.0% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 2,456,391 shares of the technology company’s stock valued at $37,804,000 after purchasing an additional 24,599 shares during the period. Institutional investors and hedge funds own 6.58% of the company’s stock.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
Read More
- Five stocks we like better than Koninklijke Philips
- MarketBeat Week in Review – 7/10 – 7/14
- Wells Fargo’s Earnings, Why Markets Are Loving The Stock
- Citigroup Leads Banking Earnings, What’s Next?
- BlackRock Kicks Off Financials Earnings Season, Gauge To Markets
- JPMorgan Chase Is In Reversal But Don’t Chase It Higher
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.
